Sign In

Login

Password

Forgot Password ? Sign Up

Câncer de próstata (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Câncer de próstata" in Portuguese language version.

refsWebsite
Global rank Portuguese rank
26nih.gov
4th place
8th place
13doi.org
2nd place
4th place
3web.archive.org
1st place
1st place
3cancer.org
3,680th place
2,816th place
3uspreventiveservicestaskforce.org
low place
low place
1stonybrook.edu
9,697th place
low place
1virginia.edu
1,041st place
985th place
1revistaonco.com.br
low place
low place
1excite.com
low place
low place
1cdc.gov
218th place
177th place
1ascopubs.org
low place
low place
1auanet.org
low place
low place
1techexplorist.com
low place
409th place

ascopubs.org

jco.ascopubs.org

auanet.org

cancer.org

cdc.gov

doi.org

dx.doi.org

excite.com

apnews.excite.com

nih.gov

ncbi.nlm.nih.gov

  • Miller, DC; Hafez, KS, Stewart, A,; et al. (2003). «Prostate carcinoma presentation, diagnosis, and staging: an update form the National Cancer Data Base». Cancer. 98. 1169 páginas. PMID 12973840 
  • van der Cruijsen-Koeter, IW; Vis AN, Roobol MJ, Wildhagen MF, de Koning HJ, van der Kwast TH, Schroder FH (julho de 2005). «Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam». Urol. 174 (1): 121-5. PMID 15947595 
  • Essink-Bot, ML; de Koning HJ, Nijs HG, Kirkels WJ, van der Maas PJ, Schroder FH (17 de junho de 1998). «Short-term effects of population-based screening for prostate cancer on health-related quality of life». J Natl Cancer Inst. 90 (12): 925-31. PMID 9637143 
  • Chuang AY, Demarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI (2007). «Immunohistochemical Differentiation of High-grade Prostate Carcinoma From Urothelial Carcinoma». 31 (8): 1246-1255. PMID 17667550. doi:10.1097/PAS.0b013e31802f5d33 
  • Bill-Axelson A, Holmberg L, Ruutu M,; et al. (2005). «Radical prostatectomy versus watchful waiting in early prostate cancer». N. Engl. J. Med. 352 (19): 1977-84. PMID 15888698. doi:10.1056/NEJMoa043739 
  • Gerber, GS; Thisted RA, Scardino PT, Frohmuller HG, Schroeder FH, Paulson DF, Middleton AW Jr, Rukstalis DB, Smith JA Jr, Schellhammer PF, Ohori M, Chodak GW (28 de agosto de 1996). «Results of radical prostatectomy in men with clinically localized prostate cancer». JAMA. 276 (8): 615-9. PMID 8773633 
  • Robson, M; Dawson N (junho de 1996). «How is androgen-dependent metastatic prostate cancer best treated?». Hematol Oncol Clin North Am. 10 (3): 727-47. PMID 8773508  Review.
  • Loblaw, DA; Mendelson DS, Talcott JA, Virgo KS, Somerfield MR, Ben-Josef E, Middleton R, Porterfield H, Sharp SA, Smith TJ, Taplin ME, Vogelzang NJ, Wade JL Jr, Bennett CL, Scher HI; American Society of Clinical Oncology (15 de julho de 2004). «American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer». J Clin Oncol. 22 (14): 2927–41. PMID 15184404  Erratum in: J Clin Oncol. 2004 November 1;22(21):4435.
  • Djulbegovic M, Beyth RJ, Neuberger MM, Stoffs TL, Vieweg J, Djulbegovic B, Dahm P (2010). «Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials». BMJ. 341: c4543. PMC 2939952Acessível livremente. PMID 20843937. doi:10.1136/bmj.c4543 
  • Moyer VA, on behalf of the U.S. Preventive Services Task, Force (maio de 2012). «Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement». Annals of Internal Medicine. PMID 22801674 
  • Chou R, Croswell JM, Dana T, Bougatsos C, Blazina I, Fu R, Gleitsmann K, Koenig HC, Lam C, Maltz A, Rugge JB, Lin K (dezembro de 2011). «Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force». Annals of Internal Medicine. 155 (11): 762–71. PMID 21984740. doi:10.1059/0003-4819-155-11-201112060-00375 
  • Qaseem A, Barry MJ, Denberg TD, Owens DK, Shekelle P (abril de 2013). «Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians». Annals of Internal Medicine. 158 (10): 761–9. PMID 23567643. doi:10.7326/0003-4819-158-10-201305210-00633 
  • Basch E, Oliver TK, Vickers A, Thompson I, Kantoff P, Parnes H, Loblaw DA, Roth B, Williams J, Nam RK (16 de julho de 2012). «Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion» (PDF). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30 (24): 3020–5. PMC 3776923Acessível livremente. PMID 22802323. doi:10.1200/JCO.2012.43.3441 
  • Jemal, A; Murray T; Ward E; Samuels A; Tiwari RC; Ghafoor A; Feuer EJ; Thun MJ (janeiro–fevereiro de 2005). «Cancer statistics, 2005». CA Cancer J Clin. 55 (1): 10–30. PMID 15661684  Erratum in: CA Cancer J Clin. 2005 Jul-Aug;55(4):259.
  • Wakai, K (fevereiro de 2005). «Descriptive epidemiology of prostate cancer in Japan and Western countries». Nippon Rinsho. 63 (2): 207-12. PMID 15714967  Review. (em japonês)
  • Yeole, BB; Sunny L. junho–dezembro de 2001. «Population based survival from prostate cancer in Mumbai (Bombay), India». Indian J Cancer. 38 (2–4): 126-32. PMID 1259345 
  • Hsing, AW; Tsao L, Devesa SS (1 de janeiro de 2000). «International trends and patterns of prostate cancer incidence and mortality». Int J Cancer. 85 (1): 60-7. PMID 10585584 
  • Osegbe, DN (abril de 1997). «Prostate cancer in Nigerians: facts and nonfacts». J Urol. 157 (4): 1340–3. PMID 9120935 
  • Di Blasio CJ, Rhee AC, Cho D, Scardino PT, Kattan MW (2003). «Predicting clinical end points: treatment nomograms in prostate cancer». Semin Oncol. 30 (5): 567-86. PMID 14571407 
  • Hellerstedt BA, Pienta KJ (2002). «The current state of hormonal therapy for prostate cancer». CA Cancer J Clin. 52 (3): 154–79. PMID 12018929. doi:10.3322/canjclin.52.3.154 
  • Feldman BJ, Feldman D (outubro de 2001). «The development of androgen-independent prostate cancer». Nature Reviews Cancer. 1 (1): 34–45. PMID 11900250. doi:10.1038/35094009 
  • Lytton, B. (2001). «Prostate cancer: a brief history and the discovery of hormonal ablation treatment». The Journal of Urology. 165 (6 Pt 1): 1859–62. PMID 11371867. doi:10.1016/S0022-5347(05)66228-3 
  • Walsh, P.C.; Lepor, H.; Eggleston, J.C. (1983). «Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations». The Prostate. 4 (5): 473–85. PMID 6889192. doi:10.1002/pros.2990040506 
  • Schally AV, Kastin AJ, Arimura A (novembro de 1971). «Hypothalamic follicle-stimulating hormone (FSH) and luteinizing hormone (LH)-regulating hormone: structure, physiology, and clinical studies». Fertility and Sterility. 22 (11): 703–21. PMID 4941683 
  • Tolis G, Ackman D, Stellos A, Mehta A, Labrie F, Fazekas AT, Comaru-Schally AM, Schally AV (março de 1982). «Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists». Proc. Natl. Acad. Sci. U.S.A. 79 (5): 1658–62. PMC 346035Acessível livremente. PMID 6461861. doi:10.1073/pnas.79.5.1658 
  • Denmeade SR, Isaacs JT (maio de 2002). «A history of prostate cancer treatment». Nature Reviews Cancer. 2 (5): 389–96. PMID 12044015. doi:10.1038/nrc801 

revistaonco.com.br

stonybrook.edu

hsc.stonybrook.edu

techexplorist.com

uspreventiveservicestaskforce.org

virginia.edu

med-ed.virginia.edu

web.archive.org